Mouse anti- Human Fatty acid-binding protein monoclonal antibody

Product Type: Monoclonal antibodies
Product Name: Mouse anti- Human Fatty acid-binding protein monoclonal antibody
Size: 100ug
Code: CSB-MA077601A0m
Immunogen: Recombinant Human Fatty acid-binding protein
Raised in: mouse
Species Reactivity: Human
Spectificity: specific for native and denatured forms
Tested Applications: ELISA, WB, and other possible application
Relevance: FABP are thought to play a role in the intracellular transport of long-chain fatty acids and their acyl-CoA esters.
Clonality: monoclonal
Isotype: IgG2a
Purity: >95% by Caprylic Acid Ammonium Sulfate Precipitation purified
Conjugate: Non-conjugated
Storage Buffer: Preservative: 0.03% Proclin 300 Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
Form: liquid
Storage: Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles
References: [1] Manabe K, Kamihata H, Motohiro M, Senoo T, Yoshida S, Iwasaka T.Urinary liver-type fatty acid-binding protein level as a predictive biomarker of contrast-induced acute kidney injury. Eur J Clin Invest. 2011 Oct 17. doi: 10.1111/j.1365-2362.2011.02620.x. [2] Dinh W, Nickl W, Füth R, Lankisch M, Hess G, Zdunek D, Scheffold T, Barroso MC, Tiroch K, Ziegler D, Seyfarth M. High sensitive troponin T and heart fatty acid binding protein: novel biomarker in heart failure with normal ejection fraction?: a cross-sectional study. BMC Cardiovasc Disord. 2011 Jul 5;11:41. [3] Ozdemir L, Elonu OH, Gocmen AY.Heart type fatty acid binding protein is more sensitive than troponin I and creatine kinase myocardial band at early stage in determining myocardial injury caused by percutaneous coronary intervention. Int Heart J. 2011;52(3):143-5. [4] Doi M, Miyoshi T, Hirohata S, Nakamura K, Usui S, Takeda K, Iwamoto M, Kusachi S, Kusano K, Ito H.Association of increased plasma adipocyte fatty acid-binding protein with coronary artery disease in non-elderly men. Cardiovasc Diabetol. 2011 May 23;10:44. [5] Tso AW, Lam TK, Xu A, Yiu KH, Tse HF, Li LS, Law LS, Cheung BM, Cheung RT, Lam KS.Serum adipocyte fatty acid-binding protein associated with ischemic stroke and early death. Neurology. 2011 Jun 7;76(23):1968-75. Epub 2011 May 11. [6] Body R, McDowell G, Carley S, Wibberley C, Ferguson J, Mackway-Jones K.A FABP-ulous rule out strategy? Heart fatty acid binding protein and troponin for rapid exclusion of acute myocardial infarction. Resuscitation. 2011 Aug;82(8):1041-6. Epub 2011 Apr 2. [7] Kamijo-Ikemori A, Sugaya T, Yasuda T, Kawata T, Ota A, Tatsunami S, Kaise R, Ishimitsu T, Tanaka Y, Kimura K. Clinical significance of urinary liver-type fatty acid-binding protein in diabetic nephropathy of type 2 diabetic patients. Diabetes Care. 2011 Mar;34(3):691-6. Epub 2011 Jan 27. [8] Figiel ?, Wraga M, Bednarkiewicz Z, Lipiec P, Smigielski J, Krzemi?ska-Paku?a M, Kasprzak JD.Direct comparison of the diagnostic value of point-of-care tests detecting heart-type fatty acid binding protein or glycogen phosphorylase isoenzyme BB in patients with acute coronary syndromes with persistent ST-segment elevation. Kardiol Pol. 2011;69(1):1-6. [9] Thuijls G, van Wijck K, Grootjans J, Derikx JP, van Bijnen AA, Heineman E, Dejong CH, Buurman WA, Poeze M. Early diagnosis of intestinal ischemia using urinary and plasma fatty acid binding proteins. Ann Surg. 2011 Feb;253(2):303-8. [10] Giannessi D, Piacenti M, Maltinti M, Rossi A, Di Cecco P, Startari U, Cabiati M, Panchetti L, Del Ry S, Morales MA. Heart-type fatty acid binding protein is an early marker of myocardial damage after radiofrequency catheter ablation. Clin Biochem. 2010 Oct;43(15):1241-5. Epub 2010 Aug 13. [11] Kalay N, Yarlioglues M, Ardic I, Kaya MG, Vardar A, Inanc T, Dogan A, Ikizceli I, Koç F, Oguzhan A, Ergin A.The role of heart-type fatty acid-binding protein in predicting properties of coronary atherosclerosis in patients with acute coronary syndrome. Coron Artery Dis. 2010 Nov;21(7):435-40. [12] Doi K, Noiri E, Maeda-Mamiya R, Ishii T, Negishi K, Hamasaki Y, Fujita T, Yahagi N, Koide H, Sugaya T, Nakamura T.Urinary L-type fatty acid-binding protein as a new biomarker of sepsis complicated with acute kidney injury. Crit Care Med. 2010 Oct;38(10):2037-42. [13] Relja B, Szermutzky M, Henrich D, Maier M, de Haan JJ, Lubbers T, Buurman WA, Marzi I.Intestinal-FABP and liver-FABP: Novel markers for severe abdominal injury. Acad Emerg Med. 2010 Jul;17(7):729-35. [14] Kim YC, Cho YK, Lee WY, Kim HJ, Park JH, Park DI, Sohn CI, Jeon WK, Kim BI, Park SE, Rhee EJ, Park CY, Oh KW, Park SW, Kim SW, Ryu SH.Serum adipocyte-specific fatty acid-binding protein is associated with nonalcoholic fatty liver disease in apparently healthy subjects. J Nutr Biochem. 2011 Mar;22(3):289-92. Epub 2010 Jun 25. [15] Matsui Y, Satoh K, Mutsukura K, Watanabe T, Nishida N, Matsuda H, Sugino M, Shirabe S, Eguchi K, Kataoka Y. Development of an ultra-rapid diagnostic method based on heart-type fatty acid binding protein levels in the CSF of CJD patients. Cell Mol Neurobiol. 2010 Oct;30(7):991-9. Epub 2010 May 25. [16] Muehlschlegel JD, Perry TE, Liu KY, Fox AA, Collard CD, Shernan SK, Body SC.Heart-type fatty acid binding protein is an independent predictor of death and ventricular dysfunction after coronary artery bypass graft surgery. Anesth Analg. 2010 Nov;111(5):1101-9. Epub 2010 May 10. [17] Evennett NJ, Hall NJ, Pierro A, Eaton S.Urinary intestinal fatty acid-binding protein concentration predicts extent of disease in necrotizing enterocolitis. J Pediatr Surg. 2010 Apr;45(4):735-40. [18] Funaoka H, Kanda T, Fujii H.Intestinal fatty acid-binding protein (I-FABP) as a new biomarker for intestinal diseases. Rinsho Byori. 2010 Feb;58(2):162-8. [19] Akbal E, Özbek M, Güne? F, Akyürek Ö, Üreten K, Deliba?? T.Serum heart type fatty acid binding protein levels in metabolic syndrome. Endocrine. 2009 Dec;36(3):433-7. Epub 2009 Oct 6.
Intended use: